Cargando…

Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome

BACKGROUND: Faecal microbiota transplantation (FMT) seems to be a promising treatment for irritable bowel syndrome (IBS) patients. In Western countries (United States and Europe), there is a female predominance in IBS. A sex difference in the response to FMT has been reported recently in IBS patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Salhy, Magdy, Casen, Christina, Valeur, Jørgen, Hausken, Trygve, Hatlebakk, Jan Gunnar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Clinical Trials Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117742/ https://www.ncbi.nlm.nih.gov/pubmed/34025075 http://dx.doi.org/10.3748/wjg.v27.i18.2219

Ejemplares similares

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Density of Musashi-1-positive stem cells in the stomach of patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Stomach antral endocrine cells in patients with irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2018)

Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2014)

Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (Review)
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report
por: El-Salhy, Magdy, et al.
Publicado: (2013)

The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
por: Mazzawi, Tarek, et al.
Publicado: (2021)

Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease
por: El-Salhy, Magdy, et al.
Publicado: (2017)

Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study
por: Mazzawi, Tarek, et al.
Publicado: (2022)

Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2019)

Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome
por: MAZZAWI, TAREK, et al.
Publicado: (2014)

Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Interaction between diet and gastrointestinal endocrine cells
por: EL-SALHY, MAGDY, et al.
Publicado: (2016)

Increased Chromogranin A Cell Density in the Large Intestine of Patients with Irritable Bowel Syndrome after Receiving Dietary Guidance
por: Mazzawi, Tarek, et al.
Publicado: (2015)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Postprandial Symptoms in Patients With Functional Dyspepsia and Irritable Bowel Syndrome: Relations to Ultrasound Measurements and Psychological Factors
por: Steinsvik, Elisabeth K, et al.
Publicado: (2020)

The role of peptide YY in gastrointestinal diseases and disorders
por: EL-SALHY, MAGDY, et al.
Publicado: (2013)

Low Densities of Serotonin and Peptide YY Cells in the Colon of Patients with Irritable Bowel Syndrome
por: El-Salhy, M., et al.
Publicado: (2011)

Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis
por: El-Salhy, Magdy, et al.
Publicado: (2012)

Diet in irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

Chronic fatigue in patients with unexplained self-reported food hypersensitivity and irritable bowel syndrome: validation of a Norwegian translation of the Fatigue Impact Scale
por: Lind, Ragna, et al.
Publicado: (2013)

Chromogranin A cell density in the rectum of patients with irritable bowel syndrome
por: EL-SALHY, M., et al.
Publicado: (2012)

Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome
por: Mazzawi, T, et al.
Publicado: (2015)

Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome
por: El-Salhy, Magdy
Publicado: (2020)

Amelioration of Severe TNBS Induced Colitis by Novel AP-1 and NF-κB Inhibitors in Rats
por: El-Salhy, Magdy, et al.
Publicado: (2014)

Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome
por: Mazzawi, T, et al.
Publicado: (2016)

Faecal microbiota transplantation simultaneously ameliorated patient's essential tremor and irritable bowel syndrome
por: Liu, Xu‐juan, et al.
Publicado: (2020)

Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2020)

The role of diet in the pathophysiology and management of irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome
por: Mazzawi, Tarek, et al.
Publicado: (2016)

Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats
por: El-Salhy, Magdy, et al.
Publicado: (2016)

Tryptophan: ‘essential’ for the pathogenesis of irritable bowel syndrome?
por: Berstad, Arnold, et al.
Publicado: (2014)

Dietary fiber in irritable bowel syndrome (Review)
por: El-Salhy, Magdy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kb72sm6o2cnlbng61e8e2brtuf